Maverick Synergy is the third generation Java SSH API developed by JADAPTIVE Limited (previously known as SSHTOOLS Limited). It is a pure Java implementation of the SSH2 protocol enabling you to ...

GeeTest, a global leader in bot management and online security solutions serving over 360,000 enterprises worldwide, today ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Though most players enjoy Minecraft as a regular survival game, it is a massive sandbox that has loads of technical moving parts that are constantly at work. A few enthusiasts and mod developers like ...

At the heart of modern finance beats a paradox. Every innovation aimed at speed and efficiency collides with an expanding web of regulation. What was designed to make finance safer often slows it down ...

Users can also add the first and final frame of a Veo 3.1-generated video The new Extend feature lets users create AI videos longer than a minute Veo 3.1 is currently available via the Flow app and ...

As expected after days of leaks and rumors online, Google has unveiled Veo 3.1, its latest AI video generation model, bringing a suite of creative and technical upgrades aimed at improving narrative ...

API manufacturing has many major challenges. However, implementing the right flow chemistry approaches can make a significant impact for driving success. Join us for this valuable webinar to learn ...

Flowserve Corporation and Chart Industries, Inc. announced a merger of equals, aiming for diversification and $300 million in cost synergies, but investors reacted cautiously. Chart shareholders will ...

In March 2025, the Central Java Gender Justice Agreement was formally announced, marking a historic breakthrough in the fight against gender-based violence and harassment (GBVH) in Indonesia’s garment ...

The pharmaceutical services provider Sterling Pharma Solutions will produce hypericin, the active ingredient in an oncology drug being developed by the biotech firm Soligenix. Sterling says it will ...